Search results
Boeing Stock Rises 7.4% YTD: Can the Turnaround Gain Momentum?
The Boeing Company’s BA shares have risen 7.4% year to date compared with the Zacks Aerospace-Defense industry’s growth of 7%. The government’s inclination toward strengthening the nation’s defense
Ituran Location and Control Q2 Earnings Call Highlights
Key Points
- Interested in Ituran Location and Control Ltd.? Here are five stocks we like better.
- Record quarterly performance: Second-quarter revenue rose 21% year over year to $104.8 million
Chipmos Technologies Q2 Earnings Call Highlights
Key Points
- Interested in Chipmos Technologies? Here are five stocks we like better.
- ChipMOS reported a major earnings rebound in Q2 2026: Revenue rose 28.7% year over year to NT$7.38 billion
Global-e Online Q2 Earnings Call Highlights
Key Points
- Interested in Global-e Online Ltd.? Here are five stocks we like better.
- Global-e delivered a strong second quarter: GMV rose 44% year over year to $2.089 billion, revenue increased
National Vision Q2 Earnings Call Highlights
Key Points
- Interested in National Vision Holdings, Inc.? Here are five stocks we like better.
- Second-quarter results improved: Revenue rose 2.5% to $499 million, adjusted comparable-store
Eastern Q2 Earnings Call Highlights
Key Points
- Interested in Eastern Company (The)? Here are five stocks we like better.
- Q2 results weakened: Continuing-operations sales fell 12% year over year to $61.8 million, while adjusted
Anterix Q1 Earnings Call Highlights
Key Points
- Interested in Anterix Inc.? Here are five stocks we like better.
- Anterix reported $2 million in fiscal Q1 2027 revenue, about $11 million in gains from broadband license exchanges
Aquestive Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Aquestive Therapeutics, Inc.? Here are five stocks we like better.
- Aquestive plans to resubmit Anaphylm’s FDA application before the end of Q3 after revised packaging
Altimmune Q2 Earnings Call Highlights
Key Points
- Interested in Altimmune, Inc.? Here are five stocks we like better.
- Altimmune has begun enrolling its global Phase III PERFORMA trial of pemvidutide for MASH, with about 300 sites
Bilfinger Q2 Earnings Call Highlights
Key Points
- Interested in Bilfinger SE? Here are five stocks we like better.
- Bilfinger’s second-quarter performance improved: Revenue rose 7% to €1.45 billion, EPS increased 15% to €1.47, and
CoreWeave's $129 Billion AI Backlog Changes the Bull Case
Key Points
- Interested in CoreWeave Inc.? Here are five stocks we like better.
- CoreWeave's Q2 revenue grew 113% year-over-year and its backlog topped $104 billion, sparking a sharp stock rally
Tesla's Robotaxi Reality Check: Time to Deliver
Key Points
- Interested in Tesla, Inc.? Here are five stocks we like better.
- Tesla's automotive margins have compressed to 1.4% amid price cuts, pushing quarterly free cash flow negative to $1.09
Is Maximus Stock Worth Buying as Low Valuation Meets Contract Risk?
Maximus, Inc. MMS presents investors with a sharp valuation-versus-visibility trade-off. The stock trades at a deep earnings discount and still carries favorable fundamental Style Scores, while
Can Maximus Weather the VA Contract Hit and Rebuild Earnings Momentum?
Maximus, Inc. MMS faces near-term earnings reset after a temporary change to a major federal contract removed a meaningful profitability contributor for the second half of fiscal 2026.
The central
Tesla's Japan Sales Surging: Can Its Delivery Network Keep Up?
U.S. electric vehicle (EV) and tech giant Tesla TSLA is gaining momentum in a market that has historically been difficult for foreign automakers to crack. After selling more than 10,000 vehicles in
Can NuScale's TVA Opportunity Unlock Its Next Growth Phase?
NuScale Power Corporation SMR is approaching a potentially important commercial inflection point as ENTRA1 Energy advances discussions with the Tennessee Valley Authority toward definitive power
Can NuScale's Commercial Potential Justify Its Valuation?
NuScale Power Corporation SMR has a credible path toward commercializing its small modular reactor technology, supported by U.S. regulatory approval, supplier readiness and ample liquidity. The
3 Large-Cap Value Funds to Play Safe Amid Ongoing Economic Uncertainty
Markets have somewhat stabilized, with major indexes coming off their strongest week since April. However, volatility continues as several factors continue to dent investors’ confidence.
Oil prices
Is Regency Worth Buying as Leasing Strength Meets Development Risk?
Regency Centers Corporation REG is pairing high occupancy and healthy rent growth with a larger development commitment and higher financing costs. The investment case turns on whether durable
The Zacks Analyst Blog Highlights Caterpillar, Komatsu, Terex and Astec Industries
For Immediate Release
Chicago, IL – August 12, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and


